Skip to main content

Day: May 4, 2021

CORRECTION: Vistin Pharma ASA : Key information relating to the cash dividend

This is a correction of the announcement from 30.04.2021, 11:22 CEST. Reason for the correction: Change of record date. Vistin Pharma ASA : Key information relating to the cash dividend to be paid by Vistin Pharma ASA Dividend amount: NOK 0.5 Declared currency: NOK Last day including right: 20 May 2021 Ex-date: 21 May 2021 Record date: 25 May 2021 Payment date: 3 June 2021 Date of approval: 20 May 2021For further information, please contact: Alexander Karlsen CFO +47 97 05 36 21 alexander.karlsen@vistin.comThis information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.  

Continue reading

Changed result for fiscal year 2020/21

To Nasdaq OMX Copenhagen A/S Public announcement no. 494 May 4, 2021 2020/21 RESULTS EXPECTED TO EXCEED THE GUIDANCE IN GLUNZ & JENSEN HOLDING A/S Glunz & Jensen announces that the expectations for 2020/21 have been revised. Glunz & Jensen has had a better-than-expected result for 2020/21, primarily due to a strong fourth quarter and because the positive effects of the consolidation of activities in Glunz & Jensen (Slovakia) have materialized earlier than expected. The full year revenue for 2020/21, which ended March 31, 2021, is expected to be approximately 137 MDKK. The previous outlook was at 130-140 MDKK for the full year 2020/21. The EBITDA before non-recurring items and fair value adjustment on investment properties is expected to be approximately 19 MDKK. It was previously communicated in the range of DKK 12-14...

Continue reading

Interim Financial Report of Jyske Realkredit A/S, Q1 2021

Jyske Realkredit A/S – Interim Financial Report, Q1 2021 To NASDAQ Copenhagen A/S                                                                                                                  4 May 2021                                                                                                                 Announcement No. 46/2021 Interim Financial Report of Jyske Realkredit A/S, Q1 2021 On May 4, 2021 the Board of Directors has approved the Interim Financial Report of Jyske Realkredit A/S, Q1 2021. Please see attached file. Yours sincerely,Jyske Realkredit A/S Carsten Tirsbæk MadsenCEO Direct phone (+45) 89 89 90 50E-mail: ctm@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial report of Jyske Realkredit, Q1 2021.pdfAttachment...

Continue reading

Jyske Bank Interim Financial Report Q1 2021

Earnings per share of DKK 11.6 (Q1 2020: DKK -11.1)Jyske Bank expects earnings per share of DKK 31-35 in 2021Core income of DKK 2,235m (Q1 2020: DKK 1,803m)Core expenses of DKK 1,171m (Q1 2020: DKK 1,346m)Loan impairment charges of DKK 10m (Q1 2020: DKK 1,003m)Pre-tax profit of DKK 1,128m, corresponding to a pre-tax return on equity of 12.9% p.a. (Q1 2020: DKK -996m and -10.3% p.a.)Net profit of DKK 883m, corresponding to a return on equity of 10.0% p.a. (Q1 2020: DKK -780m and -10.3% p.a.)Capital ratio of 23.2% (Q1 2020: 21.5%), hereof common equity tier 1 capital (CET1) ratio of 18.0% (Q1 2020: 16.7%)Jyske Bank expects a pre-tax profit of DKK 3.0bn-3.4bn and a net profit of DKK 2.3bn-2.7bn in 2021Effective 11 June 2021, Jyske Bank changes the variable interest rate on corporate clients’ demand deposits to...

Continue reading

Verona Pharma to Present Expanded Analysis of Phase 2b COPD Data with Ensifentrine at the American Thoracic Society 2021 International Conference

Posters highlight ensifentrine’s safety profile and its potential to improve lung function and quality of life irrespective of COPD severity LONDON and RALEIGH, N.C., May 04, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces three abstracts highlighting new analyses from Phase 2b clinical trials with nebulized ensifentrine in chronic obstructive pulmonary disease (“COPD”) have been accepted by the American Thoracic Society International Conference (“ATS”) 2021. The abstracts are published on the ATS website and in the peer reviewed publication, American Journal of Respiratory and Critical Care Medicine. The abstracts include a new subgroup analysis evaluating the effect of ensifentrine by COPD severity from the 4-week...

Continue reading

Mkango Announces Results Of Flotation Piloting With Significantly Higher Recoveries And Concentrate Grade, And Commencement Of Hydrometallurgical Piloting

LONDON and VANCOUVER, British Columbia, May 04, 2021 (GLOBE NEWSWIRE) — Mkango Resources Ltd. (AIM/TSX-V: MKA) (the “Company” or “Mkango”) is pleased to announce results of the flotation pilot plant programme completed at ALS Metallurgy in Perth, Australia, which was effective in scaling up a new, optimised flotation regime for the Songwe Hill Rare Earths Project (“Songwe”) located in Malawi.The flotation piloting programme demonstrated that the flotation process is robust and straightforward to scale up and the results support a significant increase in both flotation recoveries and concentrate grade for the feasibility study versus the design criteria for the 2015 pre-feasibility study for Songwe:Significant increase in flotation recovery of total rare earth oxides (“TREO”) to 74% from 67%; Tripling...

Continue reading

B Communications, Bezeq’s Controlling Shareholder, Appoints Ajit Pai, Former Chairman of the U.S. FCC, to its Board of Directors

Tel Aviv, Israel , May 04, 2021 (GLOBE NEWSWIRE) — B Communications Ltd. (NASDAQ Global Select Market and TASE: BCOM) (“BCOM”), a holding company with a controlling interest in Israel’s largest telecommunications provider, Bezeq, The Israel Telecommunication Corporation Limited (“Bezeq”) (TASE: BEZQ), today announced the appointment of Ajit Pai, the former Chairman of the U.S. Federal Communications Commission (“FCC”), to its Board of Directors, effective May 4, 2021. Prior to joining Searchlight Capital Partners, L.P. (“Searchlight”) as a Partner, Mr. Pai was the Chairman of the FCC, which he led from 2017 until 2021. He first joined the FCC as a Commissioner in 2012. During Mr. Pai’s tenure as Chairman, he implemented major initiatives to help close the digital divide; advance U.S. leadership in 5G, Open Radio Access Networks,...

Continue reading

Pandora Launches DKK 500 Million Share Buyback Programme

The Board of Directors of Pandora has decided to launch a share buyback programme, under which Pandora will buy back own shares of a maximum consideration of DKK 500 million in the period from 5 May 2021 to 13 August 2021 at the latest, both days inclusive. The purpose of the programme is to reduce the Company´s share capital and to meet obligations arising from company incentive programmes. The share buyback programme is implemented in accordance with the safe harbour rules in Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 (market abuse regulation). Pandora has appointed Danske Bank as lead manager of the programme. The programme will be implemented under the following framework:The maximum total consideration for Pandora shares bought back in the period of the programme is DKK 500 million; Under...

Continue reading

GLOBAL WARMING SOLUTIONS, INC. ANNOUNCES SUBSIDIARY “GREEN HOLISTIC SOLUTIONS, INC.” TO SPIN OFF ITS AGRICULTURAL DIVISION TO SHAREHOLDERS

Temecula, CA, May 04, 2021 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc., (OTC MARKETS: “GWSO”), a worldwide developer of technologies that help mitigate Global Warming and its effects on the Planet announces its “Agricultural Subsidiary” which is called “Green Holistic Solutions, Inc.”, will be filing a “Form S-1” (Prospectus) with the “SEC” (Securities and Exchange Commission). It will be “Spun-Off” as a stand-alone “Public Entity”. In conjunction with the spin-off, “GWSO” shareholders will be awarded shares in the proposed public entity based on their holdings in “GWSO”. The company expects to file the appropriate documents with the SEC within the next 45 days. Every Shareholder of record will receive a “Free Dividend” of One (1) Share of “Green Holistic Solutions, Inc.” for every Ten (10) Shares they currently own in “GWSO”. Michael...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.